The petition was related to a demand of Rs 962.75 crores (including Rs 329.33 crores in interest) raised by the Income Tax ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for ...

Read here for an analysis of Zai Lab’s (ZLAB) strategic global partnerships, leading products, and growth potential in the ...

EMA’s human medicines committee recommends approval of GSK’s single-vial, fully liquid presentation of Menveo meningococcal vaccine: London, UK Wednesday, September 25, 2024, ...

In a recent legal development, Hindustan Unilever (NS: HLL) faced a setback regarding a tax dispute involving a significant ...

The application of IT for protecting and improving people’s health and the implementation of electronic medical records (EMR) ...

This tax demand was raised against HUL over non-deduction of TDS while making remittance payment for an acquisition from GSK ...

While health innovation in Vietnam is taking place strongly, many challenges prevent the sector from unlocking its full ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that the Arexvy vaccine (MAL24086007ARZ) has been approved in Malaysia for respiratory syncytial virus (RSV). RSV is a common respiratory ...

Corporate sustainability leaders spoke about innovation and partnering with the public sector during a panel at the inaugural ...

Wave Life Sciences stock surged over 50% today due to promising data from its Duchenne Muscular Dystrophy candidate WVE-N531.